These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2358843)

  • 1. Combined modality therapy in esophageal cancer.
    Einhorn LH
    J Clin Oncol; 1990 Jul; 8(7):1286-7. PubMed ID: 2358843
    [No Abstract]   [Full Text] [Related]  

  • 2. Esophagogastric cancer--time to change the paradigm.
    O'Sullivan GC; Shanahan F
    Am J Gastroenterol; 2000 Sep; 95(9):2153-4. PubMed ID: 11007209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
    Theisen J; Siewert JR
    MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
    [No Abstract]   [Full Text] [Related]  

  • 4. Esophageal carcinoma: impact of staging on treatment.
    Siewert JR; Dittler HJ
    Endoscopy; 1993 Jan; 25(1):28-32. PubMed ID: 8453923
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment strategies for esophageal cancer.
    Nieman DR; Peters JH
    Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
    González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
    Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of esophageal cancer.
    Coia L; Engstrom P; Paul A; Hanks G
    J Clin Oncol; 1990 Jul; 8(7):1285-6. PubMed ID: 2358842
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
    Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
    Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
    Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
    Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal cancers: changing character, increasing incidence.
    McCann J
    J Natl Cancer Inst; 1999 Mar; 91(6):497-8. PubMed ID: 10088616
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of carcinoma of the esophagus.
    Seibert DG; Hill RC
    W V Med J; 1989 Feb; 85(2):53-7. PubMed ID: 2464245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Section II: pathology and pathologic staging of esophageal cancer.
    Glickman JN
    Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):167-79. PubMed ID: 12838487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal therapy for esophageal adenocarcinoma.
    Badwe RA; Vaidya JS; Bhansali MS
    N Engl J Med; 1997 Jan; 336(5):374-5; author reply 375-6. PubMed ID: 9011794
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
    Brown RE; Abbas AE; Ellis S; Williams S; Scoggins CR; McMasters KM; Martin RC
    J Am Coll Surg; 2011 Apr; 212(4):582-8; discussion 588-9. PubMed ID: 21463793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal cancer. Clinical and pathologic features.
    Gore RM
    Radiol Clin North Am; 1997 Mar; 35(2):243-63. PubMed ID: 9087202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary oesophageal carcinoma in teens.
    Kumar A; Shukla NK; Mishra MC; Shahi UP; Kapur BM
    J Surg Oncol; 1992 Aug; 50(4):254-7. PubMed ID: 1640711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Residual esophageal cancer after neoadjuvant chemoradiotherapy: frequently the mucosa and submucosa are involved].
    Brink F; Jähne J
    Chirurg; 2014 Mar; 85(3):257. PubMed ID: 24519613
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
    Fuchs HF; Hölscher AH
    Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.
    Eloubeidi MA; Wallace MB
    Gastrointest Endosc; 2001 Jul; 54(1):132-4. PubMed ID: 11447984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.